Jonathan Ben‐Ezra

4.1k total citations
85 papers, 2.9k citations indexed

About

Jonathan Ben‐Ezra is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Jonathan Ben‐Ezra has authored 85 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 26 papers in Genetics and 20 papers in Hematology. Recurrent topics in Jonathan Ben‐Ezra's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (13 papers). Jonathan Ben‐Ezra is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (13 papers). Jonathan Ben‐Ezra collaborates with scholars based in United States, Israel and Canada. Jonathan Ben‐Ezra's co-authors include Khalil Sheibani, Anna M. Wu, John J. Rossi, Roger S. Riley, Nigel Cook, D. A. Johnson, Henry Rappaport, Richard A. McPherson, Michael J. Kornstein and Carl D. Winberg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Jonathan Ben‐Ezra

83 papers receiving 2.7k citations

Peers

Countries citing papers authored by Jonathan Ben‐Ezra

Since Specialization

Citations

This map shows the geographic impact of Jonathan Ben‐Ezra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Ben‐Ezra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Ben‐Ezra more than expected).

Fields of papers citing papers by Jonathan Ben‐Ezra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Ben‐Ezra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Ben‐Ezra. The network helps show where Jonathan Ben‐Ezra may publish in the future.

Co-authorship network of co-authors of Jonathan Ben‐Ezra

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Ben‐Ezra. A scholar is included among the top collaborators of Jonathan Ben‐Ezra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Ben‐Ezra. Jonathan Ben‐Ezra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker? 2023 ·Frontiers in Oncology ·(unknown), Jonathan Ben‐Ezra, (unknown), Sigi Kay, (unknown), Howard S. Oster, Moshe Mittelman	0
2	Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis 2013 ·Cancer ·Tamar Tadmor, Lev Shvidel, Ariel Aviv, Rosa Ruchlemer, Osnat Bairey, (unknown), Yair Herishanu, (unknown), (unknown), (unknown), Jonathan Ben‐Ezra, Jacob Bejar, Aaron Polliack, (unknown)	11
3	Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival 2013 ·Leukemia Research ·Yair Herishanu, Sigi Kay, Nadav Sarid, (unknown), Rony Braunstein, (unknown), Varda Deutsch, Jonathan Ben‐Ezra, Elizabeth Naparstek, Chava Perry, Ben‐Zion Katz	17
4	Predictive Parameters for a Diagnostic Bone Marrow Biopsy Specimen in the Work-Up of Fever of Unknown Origin 2012 ·Mayo Clinic Proceedings ·(unknown), Jonathan Canaani, Rony Braunstein, Chava Perry, Jonathan Ben‐Ezra, Aaron Polliack, Elizabeth Naparstek, Yair Herishanu	21
5	Do bcl‐2 and survivin help distinguish benign from malignant B‐cell lymphoid aggregates in bone marrow biopsies? 2004 ·Journal of Clinical Laboratory Analysis ·(unknown), Jonathan Ben‐Ezra	5
6	Effect of Sample Preservation Method on Gene Expression and RNA Integrity in Acute Myelogenous Leukemia. 2004 ·Blood ·Jonathan Ben‐Ezra, Amy C. Ladd, Catherine I. Dumur, Kellie J. Archer, Alden Chesney, Andrea Ferreira‐Gonzalez, David S. Wilkinson, Carleton T. Garrett	1
7	B-cell lymphoproliferative disorders 2002 ·Hematology/Oncology Clinics of North America ·Jonathan Ben‐Ezra	5
8	Reticulocyte analysis by flow cytometry and other techniques 2002 ·Hematology/Oncology Clinics of North America ·Roger S. Riley, Jonathan Ben‐Ezra, (unknown), (unknown)	33
9	Reticulocytes and reticulocyte enumeration 2001 ·Journal of Clinical Laboratory Analysis ·Roger S. Riley, Jonathan Ben‐Ezra, Rajat Goel, (unknown)	86
10	Platelet Satellitism as Presenting Finding in Mantle Cell Lymphoma 2001 ·American Journal of Clinical Pathology ·(unknown), Jonathan Ben‐Ezra, Roger S. Riley	18
11	Malignant lymphoma can present as hepatobiliary disease 1996 ·Cancer ·(unknown), Jonathan Ben‐Ezra, Melissa J. Contos, Michael J. Kornstein	22
12	Breast conservation therapy: local tumor control in patients with pathologically clear margins who receive 5000 cGy breast irradiation without local boost 1994 ·Breast Cancer Research and Treatment ·Richard D. Pezner, Lawrence D. Wagman, Jonathan Ben‐Ezra, Tamara Odom‐Maryon	15
13	Comparison of the Clinical Microscopy Laboratory with the Cytopathology Laboratory in the Detection of Malignant Cells in Body Fluids 1994 ·American Journal of Clinical Pathology ·Jonathan Ben‐Ezra, Janet F. Stastny, (unknown), (unknown), William J. Frable	5
14	PHENOTYPE OF BILE DUCTS AND INFILTRATING LYMPHOCYTES IN GRAFT-VERSUS-HOST DISEASE 1993 ·Transplantation ·Jonathan Ben‐Ezra, Robert Stroup	2
15	Variable Rate of Detection of Immunoglobulin Heavy Chain V-D-J Rearrangement by PCR: a Systematic Study of 41 B-Cell Non-Hodgkin's Lymphomas and Leukemias 1992 ·Leukemia & lymphoma ·Jonathan Ben‐Ezra	31
16	ORIGIN OF URINARY EPIDERMAL GROWTH FACTOR IN HUMANS: EXCRETION OF ENDOGENOUS EGF AND INFUSED [¹³¹I]‐HUMAN EGF AND KIDNEY HISTOCHEMISTRY 1992 ·Clinical and Experimental Pharmacology and Physiology ·Arye Lev-Ran, David Hwang, Jonathan Ben‐Ezra, Lawrence E. Williams	12
17	Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: A clinicopathologic study of 13 patients 1991 ·Human Pathology ·Sung Sik Shin, Khalil Sheibani, Andrew J. Fishleder, Jonathan Ben‐Ezra, (unknown), Chae H. Koo, Jerome S. Burke, Raymond Tubbs, Henry Rappaport	61
18	Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease 1989 ·Human Pathology ·Jonathan Ben‐Ezra, Khalil Sheibani, William G. Swartz, Robert Stroup, S. Thomas Traweek, (unknown), Henry Rappaport	9
19	Hashimoto's thyroiditis lacks detectable clonal immunoglobulin and T cell receptor gene rearrangements 1988 ·Human Pathology ·Jonathan Ben‐Ezra, Anna M. Wu, (unknown)	11
20	Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage? 1987 ·PubMed ·Jonathan Ben‐Ezra, Carl D. Winberg, Anna M. Wu, Henry Rappaport	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact